Clinical trial
Computer-based Tutorial and Automated Speech Recognition as Supportive Means to Enhance the Patient Experience and Improve the Efficiency of the Informed Consent Process for Intravitreal Drug Injections
NCT04142164 is registered in ClinicalTrials.gov with Prim. Prof. Dr. Oliver Findl, MBA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Computer-based Tutorial and Automated Speech Recognition as Supportive Means to Enhance the Patient Experience and Improve the Efficiency of the Informed Consent Process for Intravitreal Drug Injections
- Lead sponsor
- Prim. Prof. Dr. Oliver Findl, MBA
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 24, 2019
- Completion date
- January 1, 2024
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
age-related macular degeneration, diabetic macular edema, retinal vein occlusion